How to Choose FDA-Compliant Hair Care Manufacturers: What Brands Should Look for Before Production
U.S. Hair Care Compliance Buying Guide
Verify the System Behind the “FDA-Compliant” Claim
A practical pre-production checklist for brands reviewing product classification, MoCRA obligations, formula safety, testing, labeling, quality records and post-market responsibilities.
Quick answer: Do not choose a U.S.-market hair care supplier because it displays an “FDA certificate.” FDA states that cosmetic facility registration and product listing are not product approval programs and that FDA does not issue certificates for those submissions. A stronger review checks the intended product category, current facility registration and listing responsibilities where applicable, documented GMP controls, safety substantiation, formula-specific testing, compliant labeling, batch release records, complaint handling and change control.
Regulatory note: This article is educational information for cosmetic sourcing teams, not legal advice. U.S. requirements can change, exemptions can apply, and drug-cosmetic products follow additional rules. Confirm the final product, claims, label, responsible person and supply chain with qualified regulatory counsel before launch.
“FDA compliant” is one of the most frequently misunderstood phrases in cosmetic sourcing. Buyers may see factory websites, certificates, quotations or marketplace profiles that use “FDA approved,” “FDA certified” and “FDA registered” as if they mean the same thing. They do not.
For ordinary cosmetics, FDA generally does not approve finished products or ingredients before marketing, except that certain color additives require approval for their intended use. The legal responsibility is still substantial: companies must market products that are safe under labeled or customary conditions of use, properly labeled and not adulterated or misbranded. The Modernization of Cosmetics Regulation Act of 2022, commonly called MoCRA, also established facility-registration, product-listing, safety-substantiation, adverse-event and other responsibilities.
The purpose of this FDA compliant hair care manufacturer checklist is therefore not to find one logo or document. It is to determine whether the brand, responsible person, manufacturer and other partners can collectively support a lawful, traceable and controlled U.S. launch.
What “FDA-Compliant” Should—and Should Not—Mean
A Useful Meaning
- The product category and intended use have been reviewed
- Applicable MoCRA roles and submissions are assigned
- Safety, quality and labeling records are maintained
- Claims remain within the approved regulatory pathway
- Production and release follow controlled specifications
What It Does Not Mean
- FDA has approved or endorsed the manufacturer
- Facility registration proves every product is compliant
- One test report covers every formula, package or claim
- A cosmetic can make drug claims because it is “registered”
- The brand can transfer all U.S. obligations to the factory
FDA specifically warns that cosmetic facility registration and product listing are neither cosmetic approval nor promotional programs. A current registration can be an applicable legal requirement and a useful verification point, but it must not be presented as an FDA certificate, endorsement or approval of the finished product.
Step 1: Classify the Product Before Evaluating the Factory
In the United States, classification is driven by intended use. A product used to cleanse, beautify, promote attractiveness or alter appearance may be a cosmetic. A product intended to diagnose, cure, mitigate, treat or prevent disease—or affect the structure or function of the body—may be a drug. Some products meet both definitions and must comply with both regulatory frameworks.
Claims can establish intended use through packaging, websites, advertisements, social media, distributor materials and other promotion. Changing a bottle label while continuing to advertise an unapproved drug claim online does not solve the classification problem.
| Hair Care Example | Likely Regulatory Question | Buyer Action Before Sampling |
|---|---|---|
| Cleansing shampoo | Is it marketed only to cleanse and improve appearance? | Lock cosmetic claims and product directions before label development. |
| Anti-dandruff shampoo | The treatment claim can make the product both a cosmetic and a drug. | Use a drug-compliant development route; do not treat it as an ordinary cosmetic shampoo. |
| Conditioner or hair mask | Do “repair” statements describe appearance or a physiological change? | Define measurable cosmetic endpoints such as combing, breakage or appearance. |
| Scalp serum or botanical oil | Do claims imply hair regrowth, disease treatment or altered body function? | Separate cosmetic scalp-conditioning claims from drug claims before formulation. |
| Hair color or root concealer | Are color additives permitted for the intended cosmetic use and correctly declared? | Review the exact color-additive system, product category and required warnings. |
Important hair-growth boundary: FDA lists restoring hair growth as an example of a claim that can establish drug intended use. Do not select a cosmetic manufacturer, formula or label first and attempt to solve this classification issue later.
Step 2: Map Each Company’s MoCRA Role
A private label project involves more than a factory. The label may identify a brand owner or distributor; a separate company may import the goods; laboratories may perform testing; and several facilities may manufacture or process the product. Brands should document who performs each obligation instead of assuming the manufacturer “handles FDA.”
| Party | Typical Project Role | Questions to Resolve |
|---|---|---|
| Responsible person | The manufacturer, packer or distributor whose name appears on the cosmetic label. | Who will list the product, hold safety-substantiation records, receive reports and manage serious adverse events? |
| Manufacturing or processing facility | Compounds, fills, packs or otherwise processes the cosmetic as applicable. | Does facility registration apply, is it current, and how are changes and biennial renewal controlled? |
| Brand owner / distributor | Controls commercial positioning, claims, artwork, distribution and consumer communication. | Who approves claims, label text, online advertising, complaints, changes and recalls? |
| Importer / logistics partner | Coordinates entry, shipping records and delivery into the United States. | Which records and identifiers must be available for the shipment and customs entry? |
| Testing laboratory / assessor | Generates or evaluates data supporting safety, quality, stability or claims. | Are methods, samples, acceptance criteria, reports and conclusions appropriate for the finished product? |
Under MoCRA, facilities generally renew cosmetic facility registration every two years, while the responsible person lists each marketed cosmetic product and provides updates annually, subject to applicable exemptions and other provisions. The buyer should verify current status and understand which party controls the submission—not merely collect a screenshot.
The product listing generally connects the marketed product with manufacturing or processing facilities and ingredient information. Formula changes, facility changes, discontinuation and relisting can affect the records. That is why regulatory submission management must be connected to formula and change control.
The 10-Point Manufacturer Due-Diligence Checklist
Check 1
Product Classification and Claim Control
Ask the supplier to review the product type, proposed claims, directions and active-ingredient concept before quotation. A strong supplier should identify when a brief exceeds an ordinary cosmetic pathway and pause development until the brand confirms the correct regulatory route.
Evidence to request: approved claim brief, target-market classification note, artwork review workflow and a rule preventing unapproved marketing language from being added after sample approval.
Check 2
Facility Registration and Product Listing Readiness
Determine whether the manufacturing or processing site is subject to MoCRA facility registration, whether the information is current, how registration changes are handled and who tracks biennial renewal. Confirm who acts as responsible person and who submits or maintains the product listing.
Evidence to request: current registration information where applicable, facility identifier details used for listing, responsible-person assignment and a submission/update procedure. Do not ask for an “FDA certificate” that FDA says it does not issue.
Check 3
Documented Cosmetic GMP and Quality Systems
Review controls for personnel, premises, sanitation, water, equipment, raw materials, formulas, weighing, compounding, filling, labeling, storage, deviations, rework, complaints and recalls. A certificate can support due diligence, but it does not replace an audit of the controls that apply to the proposed product.
As of August 2026, FDA’s MoCRA page continues to describe cosmetic GMP regulations as regulations the agency is required to establish and directs industry to existing GMP materials. Buyers should verify the current rule status at the time of launch and assess both current controls and readiness for future requirements.
Check 4
Raw-Material and Packaging Supplier Control
The finished product depends on approved ingredient grades and packaging components. Ask how the factory qualifies suppliers, verifies incoming materials, manages color additives, controls certificates of analysis and prevents unapproved substitution.
Evidence to request: approved supplier list, raw-material specifications, incoming inspection records, color-additive review where relevant, packaging specifications and supplier-change procedures.
Check 5
Adequate Safety Substantiation
MoCRA requires the responsible person to ensure and maintain records supporting adequate safety substantiation. The review can use relevant existing safety data, but the evidence must be scientifically robust and applicable to the ingredients, concentrations, exposure, directions, target users and finished product.
Evidence to request: formula with quantitative composition under confidentiality controls, ingredient safety data, impurity or contaminant considerations, exposure rationale, finished-product testing and a documented safety conclusion by appropriately qualified personnel.
Check 6
Formula-Specific Testing
FDA does not publish one mandatory test list for every cosmetic. That does not mean testing is optional. The testing plan should be risk-based and appropriate for the final formula, packaging, manufacturing process and intended use.
Depending on the product, discuss microbiological quality, preservative effectiveness, stability, packaging compatibility, pH, viscosity, appearance, odor, color, fill weight, performance and other product-specific criteria. An anhydrous oil, water-based scalp serum, aerosol, shampoo and hair dye require different evaluations.
Check 7
U.S. Label and Artwork Review
Review product identity, net contents, ingredient declaration, name and place of business, required contact information, directions, warnings and other applicable statements. Confirm legibility and placement on the final container and outer packaging—not only in a text document.
Evidence to request: final artwork checklist, ingredient list matched to the approved formula, principal display panel review, warning review, lot-code area and signed artwork approval. The responsible person’s label must also provide a domestic address, domestic phone number or electronic contact information through which adverse-event reports can be received.
Check 8
Batch Records, Specifications and Release
The approved sample must be translated into controlled production instructions and measurable specifications. Ask who authorizes weighing, compounding, filling and release; how deviations are documented; and what prevents shipment before results are reviewed.
Evidence to request: master formula, executed batch record, bulk and finished-product specifications, in-process records, test results, packaging reconciliation, lot coding, release authorization and retained-sample procedure.
Check 9
Complaints, Adverse Events and Recall Readiness
The brand and manufacturer need a written path for receiving, investigating, escalating and trending complaints. Under MoCRA, a responsible person must report a serious adverse event associated with a cosmetic used in the United States to FDA within 15 business days and submit qualifying new medical information received within one year.
Evidence to request: complaint form, seriousness assessment, investigation procedure, contact route, escalation timeline, batch-traceability exercise, recall procedure and an agreement defining who supplies records and samples.
Check 10
Change Control, Traceability and Import Support
Formula, raw-material supplier, manufacturing site, package, artwork, claims and test-method changes can affect safety substantiation, listing information, stability and import records. The buyer should receive written notice before a change is implemented.
Evidence to request: change-control procedure, batch-to-material traceability, distribution records, sample retention, notification agreement, updated-document process and shipment document checklist.
Which Documents Should Be Available Before Production?
| Document or Record | What It Helps Verify | Common Limitation | When to Review |
|---|---|---|---|
| Facility registration information | Applicable facility identity and current registration status | Not FDA approval or proof of product safety | Supplier qualification and renewal review |
| GMP / ISO 22716 certificate and scope | Third-party system certification where valid | Does not prove the proposed SKU passed testing | Before audit or approval |
| Formula and ingredient documentation | Composition, identity, specifications and safety review inputs | Generic SDS files alone do not substantiate the finished product | Before safety and label approval |
| Stability and compatibility protocol | The plan for evaluating the final formula-package system | A protocol is not a passing result | Before production scheduling |
| Microbiological / preservative testing | Microbial quality and preservation suitability where applicable | A different formula, package or sample may not be representative | During final-formula validation |
| Approved artwork | Label statements, ingredient declaration, warnings and traceability space | Does not control website or marketplace claims | Before printing |
| Finished-product specification | Measurable release limits for the approved product | Must match actual methods and production capability | Before mass production |
| Batch release package | Lot-specific production, test and release evidence | Cannot be completed truthfully before the batch is made and tested | Before shipment |
Build a Risk-Based Test Plan for Each Hair Care Format
Hair care products do not share one universal validation package. The test plan should follow the formula, water activity, preservation system, usage, packaging, exposure and claim risk.
| Format | Important Risks to Discuss | Possible Evaluation Areas |
|---|---|---|
| Shampoo / conditioner | Microbial control, viscosity drift, separation, fragrance and package dispensing | Microbiological quality, preservative effectiveness, stability, compatibility, pH, viscosity and fill checks |
| Hair mask / styling cream | Emulsion stability, repeated jar exposure, texture, weight and package interaction | Stability, microbiology, preservation, viscosity, centrifuge where appropriate, compatibility and performance |
| Anhydrous hair oil | Oxidation, odor/color change, leakage, dropper or pump function and consumer contamination | Oxidative stability indicators, appearance, odor, low-temperature behavior, compatibility and dispensing |
| Water-based scalp serum | Preservation, active compatibility, pH, clarity, applicator contact and claim category | Microbiology, preservation, stability, pH, assay where applicable, compatibility and claims review |
| Hair color / concealer | Permitted color additives, contamination, shade consistency, warnings and applicator behavior | Color-additive compliance, shade standards, stability, microbiology where relevant, compatibility and label review |
Manufacturer Red Flags U.S. Brands Should Not Ignore
Registration Red Flags
- Offers an “FDA certificate” as proof of product approval
- Cannot identify the registered facility behind the quotation
- Treats product listing as permanent and unrelated to formula changes
Technical Red Flags
- Uses one generic test report for several different formulas
- Cannot explain finished-product release specifications
- Changes ingredients, fragrance or packaging without written approval
Claims & Label Red Flags
- Promises hair-regrowth claims through a normal cosmetic route
- Prints artwork before the formula and ingredient list are final
- Accepts copied competitor claims without evidence review
Questions to Put in Your RFQ or Supplier Audit
- Which legal category do you believe this product and claim set falls under in the United States?
- Which facility will compound, fill and pack the product?
- Does MoCRA facility registration apply, and how is its current status maintained?
- Who will be the responsible person and complete the cosmetic product listing?
- Which GMP or quality standards are implemented, and can we review the certificate scope or audit evidence?
- What safety-substantiation information will be available for the exact formula?
- Which stability, microbiological, preservation and packaging tests do you recommend, and why?
- How do you verify color additives, restricted ingredients and supplier changes?
- Who reviews the U.S. label, ingredient declaration, warnings and online claims?
- Which lot-specific documents are issued before shipment?
- How are deviations, out-of-specification results, complaints and adverse events escalated?
- How much advance notice will we receive before a formula, supplier, site or package change?
A Practical Approval Sequence Before the Purchase Order
Gate 1
Confirm Product Category and Claims
Approve the intended-use statement, cosmetic or drug pathway, target market and preliminary claim boundaries.
Gate 2
Qualify the Facility and Responsibilities
Review facility identity, applicable registration, quality system, responsible-person role, testing ownership and document access.
Gate 3
Approve Formula and Package
Confirm the coded sample, ingredient grades, specifications, packaging components and test protocol.
Gate 4
Complete Safety, Testing and Artwork Review
Resolve test findings, document safety substantiation and approve the final label against the locked formula.
Gate 5
Authorize Production and Define Release Documents
Issue the purchase order only after responsibilities, specifications, change control, listing workflow and shipment-release package are agreed.
How KINODIN Supports U.S.-Market Project Preparation
KINODIN supports private label hair care projects from product selection and formula development through samples, packaging coordination, production and quality documentation. The scope depends on the product category, formula, claims, target market and agreed service requirements.
For a U.S.-market inquiry, buyers should provide the product type, proposed claims, benchmark, ingredient requirements, packaging, expected quantity, sales channel and launch schedule. This allows the project team to identify classification questions, technical risks, testing needs and document responsibilities before production.
Review KINODIN’s OEM and private label hair care process, browse the available hair care product categories, learn more about KINODIN, or review common sourcing questions in the private label FAQ.
Frequently Asked Questions
Does FDA approve cosmetic hair care products before sale?
Generally, FDA does not approve cosmetic products or ingredients before marketing, except that certain color additives require approval for their intended use. Companies remain responsible for product safety, labeling and compliance, and FDA can take action against products or firms that violate the law.
Is an FDA registration number proof that the finished product is compliant?
No. Facility registration and product listing are important obligations when applicable, but FDA states that they are not approval programs. Compliance also depends on classification, safety substantiation, ingredients, manufacturing, labeling, claims, records and post-market responsibilities.
Who is responsible for a cosmetic product listing?
Under MoCRA, the responsible person lists each marketed cosmetic product and provides required updates, subject to applicable provisions and exemptions. The responsible person is the manufacturer, packer or distributor whose name appears on the label.
Does FDA require one standard test package for every cosmetic?
FDA says it does not have a list of tests required for every cosmetic product or ingredient. The manufacturer or distributor is nevertheless legally responsible for product safety. Testing should be risk-based and appropriate for the formula, package, intended use and available safety evidence.
Is ISO 22716 certification the same as FDA compliance?
No. ISO 22716 can support evaluation of a cosmetic GMP system, but it does not approve the formula, label, claims, safety substantiation, MoCRA submissions or batch release. Review certificate validity and scope, then assess the product-specific controls.
Can a cosmetic scalp serum claim to regrow hair?
A claim to restore hair growth can establish drug intended use. The brand should confirm the correct regulatory pathway before formulation, labeling or advertising rather than attempting to use cosmetic registration to support a drug claim.
Can the brand finalize artwork before testing is complete?
Artwork development can begin, but final approval should wait until the formula, ingredient declaration, claims, directions, warnings and package are confirmed. Printing early creates avoidable relabeling risk when a formula, test result or regulatory review requires a change.
What should the buyer receive before shipment?
The agreed package may include lot identification, finished-product test results or certificate of analysis, production and release confirmation, packing list, shipment documents and other product- or market-specific records. Define the list in the quality agreement or purchase order before production.
Key Takeaway
Compliance Is a Controlled Project, Not a Certificate Collection
A capable hair care manufacturer should be able to show how requirements move from the brief into formula approval, testing, artwork, production, release and post-market records. Registration is one checkpoint; it is not the whole compliance system.
Before production, classify the product, assign MoCRA roles, verify the facility and quality system, approve a risk-based test plan, document safety substantiation, control claims and labels, define release records and agree on complaint and change-management responsibilities.
Official FDA References
- Modernization of Cosmetics Regulation Act of 2022 (MoCRA)
- Registration and listing of cosmetic facilities and products
- Is it a cosmetic, a drug, or both?
- Product testing of cosmetics
- Summary of cosmetics labeling requirements
- Serious adverse-event reporting for cosmetic products
FDA pages and implementation status should be rechecked before publication, formula approval and commercial launch.
Prepare Your U.S.-Market Project
Send Your Target Market and Product Brief for a Feasibility Review
Share the product category, proposed claims, benchmark, formula direction, packaging, sales channel, estimated quantity and launch schedule. KINODIN can review the development scope, sampling route and quality-document requirements that should be confirmed before production.
Request a Compliance Feasibility ReviewWritten by: KINODIN Content Team
Technical review: KINODIN R&D / Quality Team
Last reviewed: August 2026
Copyright © 2026 Foshan Younik Cosmetics Co., Limited. All Rights Reserved.